Keros Therapeutics Inc (KROS)
54.53
+1.73
(+3.28%)
USD |
NASDAQ |
May 15, 16:00
54.53
0.00 (0.00%)
After-Hours: 16:31
Keros Therapeutics Total Liabilities (Quarterly): 31.87M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 31.87M |
| December 31, 2023 | 37.81M |
| September 30, 2023 | 30.40M |
| June 30, 2023 | 30.05M |
| March 31, 2023 | 29.45M |
| December 31, 2022 | 29.36M |
| September 30, 2022 | 11.52M |
| June 30, 2022 | 15.45M |
| March 31, 2022 | 11.65M |
| Date | Value |
|---|---|
| December 31, 2021 | 12.08M |
| September 30, 2021 | 11.48M |
| June 30, 2021 | 7.805M |
| March 31, 2021 | 9.358M |
| December 31, 2020 | 7.722M |
| September 30, 2020 | 7.488M |
| June 30, 2020 | 9.077M |
| March 31, 2020 | 9.737M |
| December 31, 2019 | 10.46M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
7.488M
Minimum
Sep 2020
37.81M
Maximum
Dec 2023
17.38M
Average
11.59M
Median
Total Liabilities (Quarterly) Benchmarks
| Morphic Holding Inc | 19.18M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 14.61M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 485.82M |
| Shareholders Equity (Quarterly) | 453.95M |
| Current Ratio | 24.74 |